Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Share-Based Compensation (Tables)

v3.22.1
Share-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2021
Share-Based Payment Arrangement [Abstract]  
Schedule of stock option activity
    Outstanding share
options
    Weighted-
average
exercise
price ($)
    Weighted
average
remaining contractual life (years)
    Aggregate
intrinsic
value ($ in
thousands)
 
Options:                        
Outstanding as of December 31, 2018     3,213,497       0.447       5.839       244,579  
Granted     847,443       1.295                  
Forfeited     (368,675 )     0.599                  
Exercised     (136,461 )     0.000       2.875          
Outstanding as of December 31, 2019     3,555,804       0.652       5.024       109,779  
Granted     932,835       1.199                  
Forfeited     (494,450 )     1.042                  
Exercised     (226,155 )     0.132       2.072          
Outstanding as of December 31, 2020     3,768,034       0.767       4.626       119,146  
                                 
Granted     1,966,916       7.250                  
Forfeited     (117,863 )     0.972                  
Exercised     (155,750 )     0.602       2.684          
Outstanding as of December 31, 2021     5,461,337     3.102       5.363       16,713,971  
                                 
Exercisable as of December 31, 2021     2,854,952       0.671       3.329          
                                 
Options available for future grants     36,981                          

 

Schedule of RSUs activity
    Number of RSUs  
Outstanding as of January 1, 2021    
-
 
Granted     1,968,974  
Vested    
-
 
Forfeited    
-
 
Outstanding as of December 31, 2021     1,968,974  

 

Schedule of compensation to employees
   

Year ended December 31,

 
    2021     2020     2019  
                   
Expected term, in years     4.61-6.11       4.61       4.61  
Expected volatility     42%-46%       42.02%-42.64%       42.81%-50.15%  
Risk-free interest rate     0.49%-1.28%     0.24%-1.42%     1.51%-2.20%
Expected dividend yield     0%       0%       0%  

 

Schedule of share based compensation expense
    Year ended December 31,  
    2021     2020     2019  
                   
Research and development   $ 1,518     $ 320     $ 303  
Sales and marketing     217       65       72  
General and administrative     419       46       36  
Cost of revenues     57       8      
-
 
                         
Total share-based compensation expense   $ 2,211     $ 439     $ 411